Burning Rock Biotech Ltd (BNR) Cash Flow

Operating cash flows (indirect method)

Cash flow from continuing operating activities

41.49%-23.53M

219.00%19.06M

36.15%-30.28M

48.44%-40.84M

64.46%-40.21M

76.34%-16.02M

65.00%-47.42M

27.52%-79.20M

21.62%-113.14M

39.74%-67.71M

-1.55%-135.47M

8.17%-109.27M

-27.59%-144.36M

-23.92%-112.35M

-260.02%-133.39M

-105.26%-119.00M

-143.63%-113.14M

-80.83%-90.66M

---37.05M

--2.26B

25.28%259.34M

-64.11%-50.14M

--207.01M

---30.55M

Net income from continuing operations

----

-231.37%-52.57M

-76.29%-95.09M

---15.87M

---53.94M

Operating gains losses

----

9.61%7.72M

57.36%8.84M

--7.04M

--5.62M

Other non-cash items

----

-15.36%270.06M

0.30%2.69M

--319.06M

--2.68M

Change in working capital

----

131.73%33.32M

22.91%16.57M

---104.99M

--13.48M

-Change in receivables

----

165.04%47.41M

-431.66%-8.28M

---72.89M

--2.50M

-Change in inventory

----

-27.34%-1.08M

76.84%-1.78M

---845.00K

---7.67M

-Change in prepaid expenses

----

-353.97%-2.43M

-105.97%-1.06M

--958.00K

--17.70M

-Change in other current assets

----

-107.14%-58.00K

-53.90%-3.49M

--812.00K

---2.27M

-Change in other current liabilities

----

106.63%1.60M

1039.45%7.88M

---24.12M

---839.00K

Cash from non-recurring investing activities

Cash from operating activities

41.49%-23.53M

219.00%19.06M

36.15%-30.28M

48.44%-40.84M

64.46%-40.21M

76.34%-16.02M

65.00%-47.42M

27.52%-79.20M

21.62%-113.14M

39.74%-67.71M

-1.55%-135.47M

8.17%-109.27M

-27.59%-144.36M

-23.92%-112.35M

-260.02%-133.39M

-105.26%-119.00M

-143.63%-113.14M

-80.83%-90.66M

---37.05M

--2.26B

25.28%259.34M

-64.11%-50.14M

--207.01M

---30.55M

Investing cash flow

Net cash from continuing investing activities

----

-43.88%3.61M

33.90%8.04M

--6.44M

--6.01M

Capital expenditures

----

-43.94%3.61M

33.86%8.04M

--6.45M

--6.01M

Net cash flow from disposal of fixed assets

----

-43.08%3.61M

33.61%8.03M

--6.35M

--6.01M

Net cash flow from intangible asset transactions

----

-100.00%0.00

--18.00K

--90.00K

--0.00

Net cash flow from investment products

----

100.00%0.00

--30.31M

---168.34M

--0.00

Cash from non-current investing activities

Net cash flow from investing activities

35.83%-1.53M

-147.56%-812.00K

50.28%-987.00K

92.25%-227.00K

41.22%-2.39M

93.48%-328.00K

90.15%-1.98M

-109.53%-2.93M

68.80%-4.06M

92.48%-5.03M

72.05%-20.15M

145.47%30.73M

-104.51%-13.01M

-83.84%-66.97M

80.27%-72.08M

-122.82%-67.58M

8080.32%288.33M

-263.63%-36.43M

---365.37M

--296.10M

97.93%-3.61M

470.54%22.26M

---174.78M

---6.01M

Financing cash flow

Cash flow from continuous financing activities

--0.00

96.12%-74.00K

100.00%2.00K

100.00%0.00

81.05%-1.91M

-1618.01%-45.89M

98.56%-1.00M

99.19%-32.00K

-48.58%-10.07M

91.90%-2.67M

-676.24%-69.56M

5.48%-3.93M

-109.90%-6.78M

-57.58%-32.99M

-100.49%-8.96M

-101.53%-4.16M

6170.79%68.48M

---20.94M

--1.85B

-53.89%272.23M

-94.52%1.09M

--590.45M

--19.92M

Net cash flow from debt Issuance/repayment

----

139.69%2.26M

-104.01%-858.00K

---5.69M

--21.42M

Net cash flow from common stock issuance/repurchase

----

---3.64M

----

Net cash flow from preferred stock issuance/repurchase

----

-54.71%269.97M

942.40%12.64M

--596.13M

---1.50M

Net cash flow from other financing activities

----

---7.05M

----

Net cash from non-recurrent financing activities

Net cash from financing activities

--0.00

96.12%-74.00K

100.00%2.00K

100.00%0.00

81.05%-1.91M

-1618.01%-45.89M

98.56%-1.00M

99.19%-32.00K

-48.58%-10.07M

91.90%-2.67M

-676.24%-69.56M

5.48%-3.93M

-109.90%-6.78M

-57.58%-32.99M

-100.49%-8.96M

-101.53%-4.16M

6170.79%68.48M

---20.94M

--1.85B

-53.89%272.23M

-94.52%1.09M

--590.45M

--19.92M

Net cash flow

Beginning cash balance

-15.13%522.16M

-21.75%498.25M

-27.31%533.05M

-28.70%572.67M

-33.51%615.22M

-37.20%636.75M

-36.41%733.28M

-37.00%803.14M

-35.71%925.27M

-38.53%1.01B

-38.77%1.15B

-39.66%1.27B

-25.25%1.44B

-19.99%1.65B

-26.61%1.88B

479.60%2.11B

1859.62%1.93B

1545.72%2.06B

--2.57B

--364.54M

3.05%98.24M

13.48%125.28M

--95.33M

--110.40M

Current period cash flow changes

41.81%-24.76M

211.06%23.91M

63.95%-34.80M

43.28%-39.63M

65.17%-42.54M

75.73%-21.53M

30.58%-96.53M

42.65%-69.86M

25.64%-122.13M

57.86%-88.74M

40.47%-139.04M

46.95%-121.83M

-187.51%-164.24M

-54.15%-210.60M

53.70%-233.56M

-110.43%-229.62M

-29.52%187.68M

-405.26%-136.62M

---504.41M

--2.20B

-14.79%266.30M

-79.49%-27.04M

--312.53M

---15.06M

Effect of exchange rate changes

469.81%302.00K

275.13%5.74M

-185.47%-3.54M

-89.18%1.44M

101.08%53.00K

44.67%-3.28M

-106.44%-1.24M

-49.50%13.27M

-66.91%-4.89M

75.82%-5.92M

291.18%19.24M

177.10%26.28M

-117.60%-2.93M

68.60%-24.50M

106.07%4.92M

-2192.20%-34.09M

258.93%16.66M

-30137.60%-78.01M

---81.04M

---1.49M

94.92%4.64M

-116.43%-258.00K

--2.38M

--1.57M

Ending cash balance

-13.14%497.41M

-15.13%522.16M

-21.75%498.25M

-27.31%533.05M

-28.70%572.67M

-33.51%615.22M

-37.20%636.75M

-36.41%733.28M

-37.00%803.14M

-35.71%925.27M

-38.53%1.01B

-38.77%1.15B

-39.66%1.27B

-25.25%1.44B

-19.99%1.65B

-26.61%1.88B

479.60%2.11B

1859.62%1.93B

--2.06B

--2.57B

-10.62%364.54M

3.05%98.24M

--407.87M

--95.33M

Free cash flow

----

27.50%255.73M

-59.14%-58.18M

--200.57M

---36.56M

Currency unit

USD

Audit opinions

--

Burning Rock Biotech Ltd

6.370USD

Burning Rock Biotech Ltd

6.370

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement